EBAMed

About

EBAMed SA is a medical technology company based in Geneva, Switzerland, founded in 2018. The company specializes in non-invasive treatments for cardiac arrhythmias, utilizing advanced radiation therapy technologies such as proton therapy and external beam ablation. EBAMed develops medical devices that integrate radiation therapy with real-time motion monitoring to treat conditions like ventricular tachycardias, offering alternatives to invasive procedures and drug therapies. The flagship product, the CardioKit system, combines proton radiation therapy with ultrasound imaging and deep-learning algorithms for precise heart motion tracking. This system allows for outpatient treatments that are painless and safe for patients of all ages. EBAMed's technology aims to reduce radiation exposure to healthy tissue, increase patient throughput, and lower treatment costs. The company has raised significant funding to support the development of its products and is currently in the Series A-II funding stage, working towards clinical trials for commercial deployment.